Cargando…
Trio Haploinsufficiency Causes Neurodevelopmental Disease–Associated Deficits
Heterozygous coding mutations in TRIO are associated with neurodevelopmental disorders, including autism, schizophrenia, bipolar disorder, and epilepsy, and impair TRIO’s biochemical activities. To model mutant alleles, we ablated one or both Trio alleles from excitatory neurons in the cortex and hi...
Autores principales: | Katrancha, Sara Marie, Shaw, Juliana E., Zhao, Amy Y., Myers, Samuel A., Cocco, Alexandra R., Jeng, Amanda T., Zhu, Minsheng, Pittenger, Christopher, Greer, Charles A., Carr, Steven A., Xiao, Xiao, Koleske, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436967/ https://www.ncbi.nlm.nih.gov/pubmed/30840899 http://dx.doi.org/10.1016/j.celrep.2019.02.022 |
Ejemplares similares
-
Autoinhibition of the GEF activity of cytoskeletal regulatory protein Trio is disrupted in neurodevelopmental disorder-related genetic variants
por: Bircher, Josie E., et al.
Publicado: (2022) -
Neurodevelopmental deficits and cell-type-specific transcriptomic perturbations in a mouse model of HNRNPU haploinsufficiency
por: Dugger, Sarah A., et al.
Publicado: (2023) -
Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function
por: Levy, Aaron D., et al.
Publicado: (2018) -
Analysis of trio test in neurodevelopmental disorders
por: Kim, Se Hee, et al.
Publicado: (2022) -
DNMT3A Haploinsufficiency Results in Behavioral Deficits and Global Epigenomic Dysregulation Shared across Neurodevelopmental Disorders
por: Christian, Diana L., et al.
Publicado: (2020)